New drug showdown: can it outperform standard pills to keep advanced throat cancer at bay?
Disease control
Not yet recruiting
This study aims to see if a new intravenous drug, Becotatug Vedotin, works better than the standard oral chemotherapy (capecitabine) at preventing cancer from coming back in people with high-risk, advanced nasopharyngeal carcinoma (a type of throat cancer). It will involve about …
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC